The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Hu, Wen Qing ^a   Peng, Chun Wei ^b   Li, Yan ^b  

^a CHANGZHI MEDICAL COLLEGE   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; RIBONUCLEOPROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH CANCER; BIOSYNTHESIS; DRUG RESISTANCE; GENETICS; METABOLISM; MIDDLE AGED; MULTIDRUG RESISTANCE; PATHOLOGY; STOMACH TUMOR;

ADULT; AGED; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; STOMACH NEOPLASMS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 72849141796     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-144     Document Type: Article

References (30)

1. Recent patterns in gastric cancer: a global overview. P Bertuccio L Chatenoud F Levi D Praud J Ferlay E Negri M Malvezzi C La Vecchia, Int J Cancer 2009 125 666 673
2. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108
3. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. FM Qiu JK Yu YD Chen QF Jin MH Sui J Huang, J Exp Clin Cancer Res 2009 28 126
4. Analysis on epidemic characteristics of cancer death rate in China. WD Zhang SJ Miao, Chinese J Health Education 2009 25 246 248 (In chinese with English abstract)
5. The treatment of advanced gastric cancer: current strategies and future perspectives. A Cervantes S Rosello D Roda E Rodriguez-Braun, Ann Oncol 2008 19 Suppl 5 v103 107
6. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. D Zhang D Fan, Expert Rev Anticancer Ther 2007 7 1369 1378
7. Characteristics of Epstein-Barr virus-associated gastric cancer: a study of 235 cases at a comprehensive cancer center in U.S.A. CD Truong W Feng W Li T Khoury Q Li S Alrawi Y Yu K Xie J Yao D Tan, J Exp Clin Cancer Res 2009 28 14
8. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. S Sakuramoto M Sasako T Yamaguchi T Kinoshita M Fujii A Nashimoto H Furukawa T Nakajima Y Ohashi H Imamura, N Engl J Med 2007 357 1810 1820
9. Postopreative recurrence in gastric cancer: analysis of 59 cases. CW Peng Y Li GL Yang B Xiong MH Feng FL Cheng, Hepatogastroenterlogy 2009
10. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Y Kodera S Ito Y Mochizuki K Kondo K Koshikawa N Suzuki H Kojima T Kojima T Matsui T Takase, Eur J Surg Oncol 2009 35 1158 1163
11. Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma. L Di Lauro L Giacinti MG Arena D Sergi SI Fattoruso D Giannarelli M Lopez, J Exp Clin Cancer Res 2009 28 34
12. Multidrug resistance in cancer: role of ATP-dependent transporters. MM Gottesman T Fojo SE Bates, Nat Rev Cancer 2002 2 48 58
13. Pharmacological strategies for overcoming multidrug resistance. S Nobili I Landini B Giglioni E Mini, Curr Drug Targets 2006 7 861 879
14. Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas. A Saglam M Hayran AH Uner, APMIS 2008 116 791 800
15. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein. D Alexander T Yamamoto S Kato S Kasai, Surg Today 1999 29 401 406
16. Expression of multidrug resistance-related markers in gastric cancer. K Fan D Fan LF Cheng C Li, Anticancer Res 2000 20 4809 4814
17. Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma. DQ Yu YF Yi, Ai Zheng 2003 22 496 499
18. Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationship to expression of P-glycoprotein and glutathione S transferase-pi. J Zhang J Ji YB Ji F Yuan BY Liu ZG Zhu YZ Lin, Ai Zheng 2005 24 432 437
19. Multi-slice CT contrast-enhanced presentations of advanced gastric cancer: associations with histo-differentiation and expression of p53 and P-glycoprotein. XD Yin JH Zhao L Zhang LP Wang LQ Lu LW Wang GH Xie QZ Wu SZ Wang JP Gu, Chin Med J 2008 121 2487 2491
20. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transterases, topoisomerase-II and Lung resistance protein in primary gastric cardiac adenocarcinoma. H Shi D Lu Y Shu W Shi S Lu K Wang, Cancer Invest 2008 26 344 351
21. Multiple physiological functions for multidrug transporter P-glycoprotein? RW Johnstone AA Ruefli MJ Symth, Trends Biochem Sci 2000 25 1 6
22. Expression of multidrug resistance-associated protein 1 in invasive ovarian carcinoma: implication for prognosis. A Faggad S Darb-Esfahani R Wirtz B Sinn J Sehouli D Konsgen H Lage A Noske W Weichert AC Buckendahl, Histopathology 2009 54 657 666
23. P-glycoprotein: from genomics to mechanism. SV Ambudkar C Kimchi-Sarfaty ZE Sauna MM Gottesman, Oncogene 2003 22 7468 7485
24. ABC transpoters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? D Steinbach O Leqrand, Leukemia 2007 21 1172 1176
25. Reversal of P-glycoprotein-meidiated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells. Y Zhang X Qu X Hu X Yang K Hou Y Teng J Zhang K Sada Y Liu, J Pathol 2009 218 248 255
26. Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax. Z Han L Hong Y Han K Wu S Han H Shen C Li L Yao T Qiao D Fan, J Exp Clin Cancer Res 2007 26 261 268 (Pubitemid 47025290)
27. Regulation of multidrug resistance by ribosomal protein L6 in gastric cancer cells. J Du Y Shi Y Pan X Jin C Lin N Liu Q Han Y Lu T Qiao D Fan, Cancer BiolTher 2005 4 242 247 (Pubitemid 41351325)
28. Inhibiton of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). RW Robey S Shukla E Finley RK Oldham D Barnett SV Ambudkar T Fojo SE Bates, Biochem Pharmacol 2008 75 1302 1312
29. Current status and future of chemotherapy and biochemotherapy in gastroesophageal cancer. F Lordick D Jager, Gastrointest Cancer Res 2008 2 187 197
30. Cancer Multidrug Resistance (MDR): A Major Impediment to Effective Chemotherapy. MF Ullah, Asian Pacific J Cancer Prev 2008 9 1 6